T is estimated that approximately 6% of the population harbors intracranial berry (saccular) aneurysms. Every year, roughly 30,000 of those individuals suffer aneurysm rupture. The initial mortality rate in these cases ranges from 30 to 50%. Treatment consists of two primary modalities: 1) surgical placement of clips, and 2) endovascular embolization with coils. In both situations, the goal is exclusion of the aneurysm lumen from the parent artery. Endovascular embolization achieves this goal through formation of a physical barrier within the aneurysm lumen. In theory, this barrier should mature from the initial metallic coil mass intermixed with acute thrombus into organized cellular tissue covered by endothelium. Unfortunately, aneurysms recur in up to 21% of cases, 38 generally manifesting as growing neck remnants and compaction of the coil mass. The clinical importance of intracranial aneurysms has prompted the development of several animal surgical models: dogs, 33 rabbits, 8 and our model of choice, swine.
T is estimated that approximately 6% of the population harbors intracranial berry (saccular) aneurysms. Every year, roughly 30,000 of those individuals suffer aneurysm rupture. The initial mortality rate in these cases ranges from 30 to 50%. Treatment consists of two primary modalities: 1) surgical placement of clips, and 2) endovascular embolization with coils. In both situations, the goal is exclusion of the aneurysm lumen from the parent artery. Endovascular embolization achieves this goal through formation of a physical barrier within the aneurysm lumen. In theory, this barrier should mature from the initial metallic coil mass intermixed with acute thrombus into organized cellular tissue covered by endothelium. Unfortunately, aneurysms recur in up to 21% of cases, 38 generally manifesting as growing neck remnants and compaction of the coil mass. The clinical importance of intracranial aneurysms has prompted the development of several animal surgical models: dogs, 33 rabbits, 8 and our model of choice, swine. 7 Nevertheless, many of the studies based on these models have confounding factors, such as the presence of coils or the inconsistency of postsurgical flow dynamics. Our group therefore sought to perform a detailed, strictly controlled study of thrombosis and organization in the swine model. It is only after a thorough description of the undisturbed process that we can understand the true effect of any endovascular intervention.
Thrombus organization and healing in the swine experimental aneurysm model. Part I. A histological and molecular analysis Spontaneous aneurysm thrombosis is an uncommon phenomenon in vivo and it has been difficult to study in the clinical setting. Brownlee and colleagues 6 reported that in autopsy series, intraluminal thrombosis was found in 9 to 13% of intracranial aneurysms. It occurs most commonly in giant aneurysms; incomplete thrombosis occurs in 55% of such aneurysms and complete thrombosis in 13 to 20%. 55 Acute, unorganized thrombus alone, however, is of limited value. Whittle et al. 55 showed that, in giant aneurysms, intraaneurysmal thrombus does not protect against subarachnoid hemorrhage and has little prognostic significance. There have been reports of transient ischemic attacks 13, 15, 20, 47 and distal thromboembolism 54,55 resulting from intraaneurysmal thrombosis. Investigative priority should therefore be placed on inducing or accelerating the maturation of a more effective intraaneurysmal barrier, one that would protect against bleeding and not shed emboli. The acute thrombus should ideally act as only a provisional scaffold for subsequent organization and cellular infiltration.
Our working hypothesis is that aneurysm thrombosis and resolution represent a unique physiological process to which previous scientific studies of general wound healing may not apply. Wound healing has traditionally been described in the context of skin wounds, with a fibrin clot forming a provisional scaffold for cell migration, proliferation, and differentiation. The wound repair process then results in the restoration of tissue integrity through the formation of new structures that approximate the original function. An aneurysm lumen does not, however, represent a disruption of tissue integrity, but rather, a spatial defect. This lack of a constitutive stromal tissue differentiates aneurysm healing from healing in other wounds. We sought to more fully elucidate the process of fibrin clot replacement and organization within cerebral aneurysms by what may be novel mechanisms.
We performed detailed histological and gene expression analyses in aneurysm specimens harvested in swine at postoperative Days 1, 3, 7, 14, 30, and 90. All the aneurysms were created in a fashion that resulted in rapid thrombosis, which was confirmed angiographically before closure. The recent development of cDNA microarray technology allowed the investigation of tens of thousands of genes, as well as global expression profiling. Changes in gene expression were described as relative to time zero (Day 0), defined as the time at which the first group of animals were killed immediately after thrombosis. To our knowledge, this is the most detailed investigation of intraaneurysmal thrombus maturation and organization yet performed in an animal model.
Materials and Methods

Creation of the Lateral Aneurysm Model
All animal experiments were conducted in accordance with policies established by the UCLA chancellor's animal research committee and National Institutes of Health guidelines. Thirty-one swine (male and female animals, age range 3-4 months, weight range 30-40 kg) were used in this study. One aneurysm was constructed microsurgically in each CCA of each swine-that is, two aneurysms per animal.
The aneurysms were created using a method that has been previously reported by members of our group. 39 Under sterile conditions, a 10-cm incision was made in the midline of the neck of each of the 31 swine. A 4-cm segment of the right external jugular vein was isolated at both ends with a ligature and then divided to form an open-ended vein segment to be used as the venous graft. This vein graft was divided into two equal segments for the creation of two aneurysms of equal size; one for each carotid artery. Next, under magnification of a surgical microscope, a 3-cm segment of the right CCA was exposed and cleaned of adventitia. Two small vascular clamps were placed at each end of the isolated CCA segment to achieve temporary vessel occlusion. A 4-mm-long arteriotomy (which results in the creation of small-necked aneurysms) was performed. The aneurysm was then created with a venoarterial end-to-side anastomosis of the previously isolated venous segment to the parent carotid artery using 7-0 prolene sutures. Additional sutures were placed at both the distal and the proximal ends of the aneurysm to create a small-neck aneurysm, and an aneurysm neck size of 2 to 2.5 mm was confirmed. The aneurysm domes typically measured 8 mm in diameter.
An intraoperative carotid artery angiogram was performed to document complete thrombosis of the aneurysm. In addition, occlusion was confirmed by direct observation before surgical closure. If the aneurysm was considered to be incompletely thrombosed, an additional suture or temporary clip was placed on the aneurysm neck for 20 minutes.
Follow-up carotid angiograms were performed in each animal prior to aneurysm harvesting. Four swine were killed immediately after aneurysm thrombosis was confirmed. Specimens from these animals served as time zero reference samples (controls). Five swine were killed each day on Days 1, 3, 7, 14, and 30, and two swine were killed on Day 90. After the aneurysms were harvested, the swine were killed according to protocols approved by the animal research committee.
Histological Analysis
Aneurysms were resected en bloc with their parent arteries and photographed. Thirty-one of 62 aneurysm specimens were placed in 10% neutral buffered formalin for histological evaluation, and the rest were retained for RNA extraction.
Each specimen to be studied by histological methods was stained with H & E, elastica van Gieson, and Masson trichrome. Immunohistochemical analyses were performed using primary antibodies to ␣-SMA (Dako; dilution 1:100), VEGF (Santa Cruz Biotechnology; dilution 1:400), TGF-␤2 (R & D Systems; dilution 15:100), and anti-human macrophage antibody (MCA874G, Serotec; dilution 1:100). To assess the degree of collagen deposition, selected samples were also stained with Sirius red and immunohistochemical analysis was performed using anti-collagen type I antibody (Santa Cruz Biotechnology, dilution 1:1000).
The results of all staining and immunohistochemical studies were quantitatively analyzed using a modified version of a recently described, Adobe Photoshop-based image analysis technique. 9 We obtained photomicrographs in two areas of each aneurysm-the center and the ostium-using a fixed exposure and level of brightness. A color of interest was selected to represent a positive finding or reaction. We then used Photoshop to count the number of similarly colored pixels and express the result as a percentage of the total number of pixels in the image. To normalize the quantitative analysis, all photos were taken at the same magnification (ϫ 100; 1280 ϫ 1024 pixels). In addition, the color parameters for each assay were saved as an automated function. Staining data were analyzed using a oneway analysis of variance with Tukey-Kramer adjustments.
Isolation of RNA
The greatest amounts of histological change and activity were noted at Days 3, 7, and 14. Aneurysm RNA was extracted from three swine aneurysms obtained at each of these time points. Total RNA was harvested with a modified Trizol (Gibco) technique. Each specimen was pulverized in liquid nitrogen using a mortar and pestle and incubated in Trizol solution with gentle shaking for 1 hour at 4˚C. Total RNA was precipitated with chloroform/isopropanol, purified on a silica-membrane spin column (RNeasy Mini Kit, Qiagen), and digested with DNAse. The extracted RNA was quantified and screened for degradation via both agarose gel and the Agilent Bioanalyzer (Agilent Technologies).
Gene Expression Analysis
Because at the time of the investigation there were no commercially available microarrays for porcine genes, we elected to perform a cross-species hybridization study using a commercially available human array, a technique that has been used by various other groups. 25, 26, 29, 34, 36 We reasoned that this technique would probably suffice for our study, as the purpose of our analysis was to look for changes in relative gene expression within a species. We chose the Agilent Human 1A Oligo Microarray Kit (V2, Agilent Technologies), which includes over 18,000 well-characterized human genes and an additional 2000 expressed sequence tags. The long, 60-mer spotted oligonucleotides in the Agilent system provide greater specificity than standard 25-mer arrays, as well as presumed greater hybridization affinity in the setting of possible human-porcine basepair mismatches.
Total RNA was reverse transcribed, linearly amplified, and fluorescence labeled according to the manufacturer's protocol (Fig. 1 ). This protocol consists of a Moloney Murine Leukemia Virus reverse transcription to cDNA, and T7 polymerase-based linear mRNA amplification with Cy-3 or Cy-5 incorporation. By convention, control specimens were labeled with Cy-3 and experimental specimens with Cy-5. Control probe preparations consisted of pooled RNA from multiple Day 0 aneurysm specimens. The amount of loaded RNA probe was doubled compared with the standard protocol (1.5 g instead of 0.75 g) in order to increase signal strength in the setting of possible cross-species sequence mismatches, but hybridization and washing stringencies of the original protocol were preserved. Arrays were hybridized for 16 hours in a rotating hybridization oven at 60˚C.
Microarray signal expression data were obtained using the Agilent Feature Extraction software (version 7.5.1). Standard background subtraction and Lowess normalization were utilized. The list of genes for analysis was filtered for only those spots displaying raw signal of at least double the background signal on every array. We used SPSS (SPSS, Inc.), GeneSpring (Silicon Genetics), and EASE (National Institutes of Health) software for data analysis. Agilent arrays are dual-channel arrays and are therefore based on competitive hybridization of control versus sample probes on a single chip. Therefore gene expression was evaluated as the ratio of signal intensity of Day 3, Day 7, or Day 14 specimens versus time zero reference samples on a per array basis. Thresholds of twofold upregulation or 50% downregulation were established (p Ͻ 0.05), with values between these cut-off points deemed not significantly changed.
Based on the array data, we further evaluated several genes using quantitative real-time PCR. For each specimen, cDNA was synthesized using 0.5 g of total RNA and an RT-for-PCR kit (BD Biosciences). Real-time primers and probes based on the porcine sequences of IGF1, IGFBP5, CCL2, and the human sequence of CXCL14 (Fig. 2) were designed by software-assisted sequence analysis (Applied Biosystems) and labeled with 6-carboxyfluorescein (FAM) and TAMRA. Real-time PCR was performed on the ABI Prism 7700 with the TaqMan Universal Master Mix (Applied Biosystems); GAPDH glyceraldehyde-3-phosphate-dehydrogenase (labeled with VIC fluorescent dye and TAMRA) served as an internal control, and RNA from Day 0 was used as the calibrator. Limiting primer concentrations and amplification efficiencies in multiplex reactions were validated before testing each sample. In each reaction, 12.5 ng of cDNA template was used. Data were analyzed using the multiplex comparative threshold cycle method. Each aneurysm specimen was assayed individually, in triplicate, with no pooling. a mild-to-moderate amount of fibrous tissue was noted to cover the aneurysm dome. At Day 14, there was a further increase in fibrous tissue covering the aneurysm surface. The aneurysms were also smaller and more irregular in contour, losing their original round shape. At Day 30, the aneurysms were thickened and significantly shrunken. By Day 90, only a small triangular fibrous remnant was noted.
General Histological Observations
Each aneurysm was sectioned coaxially with the parent artery. Midsection slices of the aneurysm, showing the full volume of the dome and the ostium, were collected. In specimens harvested at Day 1 we found fresh thrombus still filling the aneurysm without evidence of cellular infiltration and/or early thrombus organization. In Day 3 samples examined with routine H & E staining, we found polymorphonuclear leukocytes and eosinophils infiltrating the thrombus. Factor VIII immunohistochemical analysis confirmed the presence of viable endothelium (data not shown). Interestingly, Day 3 specimens also demonstrated a delicate reticular network of connective tissue arising from the inner wall of the aneurysm and converging centrally (Fig. 4) . Although this tissue was initially suspected to be some form of fibrillary collagen, the results of both Sirius red and collagen type I immunostaining of this area were negative.
Day 7 specimens demonstrated more prominent leukocyte infiltration and partial thrombus organization. Myofibroblasts positive for ␣-SMA were seen emanating from the periphery into the center of the thrombus. Masson trichrome staining did not show significant collagen deposition. Day 14 samples demonstrated a further increase in myofibroblast infiltration, as well as surrounding fibrocellular components. The center of the thrombus was replaced with spindle-shaped cells and ECM components, primarily collagen ( Fig. 5 ). At Days 30 and 90, the vastly shrunken aneurysms were small masses of solid connective tissue containing large amounts of collagen.
Immunohistochemical assays for macrophage activity demonstrated numerous macrophages lining the inner wall of the aneurysm at Day 3. At Day 7, there was progressive macrophage infiltration toward the center of the aneurysm (Fig. 6) . At Day 14, this central concentration of macrophages began to dissipate, and very few macrophages were observed along the periphery of the aneurysm.
Quantitative Histological Analysis
Myofibroblast proliferation was highlighted through ␣-SMA staining. No significant intraaneurysmal staining was observed in specimens obtained on Day 0 or Day 3, but there was a marked increase in immunoreactivity at Day 7, which peaked at Day 14 (Fig. 7A) . Thereafter, ␣-SMA signal showed progressive decline through Day 90. Myofi-broblast signal in the center of the aneurysm tended to lag behind that in the periphery. On Day 90, only slight ␣-SMA staining was observed in the center and neck of the aneurysm.
The amount of collagen deposition seen with Masson trichrome staining was also quantified (Fig. 7B) . This analysis demonstrated progressively increasing collagen deposition throughout the time course of the study. Immunohistochemical assay for VEGF showed a slight increase in staining signal at Days 14 and 30. However, overall signal for both TGF-␤2 (Fig. 7C) and VEGF ( Fig. 7D ) was very low throughout the time course.
Gene Expression Analysis
We first performed a Kolmogorov-Smirnov test on the processed data using the SPSS statistical software (data not shown). The findings confirmed that the expression data were approximately normally distributed (p value range 0.68-0.89), validating the use of parametric tests.
The data from the total time course were analyzed by t-test using the GeneSpring software. The null hypothesis was that the mean gene expression in the experimental sample was unchanged from the time zero reference sample (p Ͻ 0.05). Visual inspection of the data showed two dominant expression patterns-generalized increase in gene expression and generalized decrease in gene expression (Fig. 8) .
The significantly altered genes are listed in Appendices 1 through 6, which may be viewed online at www.thejns. org. In all, 1109 different genes were found to be significantly up-or downregulated during surgical aneurysm healing, although not all simultaneously. At Day 3, 603 genes demonstrated expression levels significantly different from controls. Of these, 231 genes were upregulated, and 372 were downregulated. At Day 7, 629 genes were significantly changed: 255 genes were upregulated, and 374 genes were downregulated. At Day 14, 606 genes were significantly changed: 127 genes were upregulated, and 479 downregulated. The approximately 600 genes that were active at any give time accounted for approximately 3% of the 20,229 genes represented on the array. The degree of upregulation in expression ranged from twofold (the arbitrarily selected minimum threshold) to 48-fold (SPP1 at Day 14, GenBank ID NM_000582). The degree of downregulation ranged from a 50% reduction in expression to a 98% reduction (malonyltransferase at Day 14, GenBank ID NM_ 014507).
To investigate the functional aspects of this expression profile, the lists of significantly changed genes were analyzed with the EASE bioinformatics package. 21 The EASE software performs functional clustering by accessing an annotated ontology to identify the enrichment of particular biological functions or processes within the specified gene set. A modified Fischer exact test generates an EASE score that assesses statistical significance. We chose the ontological classification system maintained by the Gene Ontology Consortium, the recognized international standard. Prob-ability values of less than 0.05 in the analysis of EASE scores were considered significant.
Complete EASE analysis results are provided in Appendix 7, which may be viewed online at www.thejns.org. Based on the initial analysis of these results, we further grouped the ontological terms into eight general functional classes (Tables 1 and 2 and Fig. 9 ). Early in healing, at Day 3, there was a marked enrichment of upregulated genes in Class 1 (genes related to energy metabolism), particularly genes related to glucose metabolism and aerobic/anaerobic pathway regulation. There was also an early enrichment of upregulated genes in Class 2 (genes related to protein synthesis). Genes related to organogenesis/ECM (Class 3) and cell proliferation (Class 4) were generally expressed throughout the time course. Functional clusters related to intercellular communication, cytokines, inflammation, and intracellular signaling (Class 5) were generally more active earlier, at Day 3, and later, at Day 14. Interestingly, significantly more of these genes were downregulated. Class 7 genes, those linked to cytoskeleton/contraction were expressed later in the time course, at Days 7 and 14. Class 8 genes represent those ontologically classified functions that did not fit a particular larger biological theme.
Although EASE provides an expression profile of all the significantly changed genes in our model, much of the prior research in the field of vascular biology has focused on two key areas: 1) cytokine/chemokine molecular biology, and 2) ECM/wound healing. Therefore, we compiled a list of 827 genes related to cytokines, chemokines, their receptors, and other immunoregulatory products. We also compiled a list of 109 genes known to produce various cell adhesion molecules, ECM proteins, proteases, and their inhibitors. These two lists were cross-matched to our list of significantly changed genes.
The results of the evaluation of cytokine-related genes were subdivided based on expression over time and whether they exhibited primarily upregulation or downregulation (Tables 3-5 ). Several members of the IGF axis were among the group of significantly changed genes. At Day 7, IGF1 was upregulated fourfold, while IGF2 and IGFBP2 were downregulated by 50%. At Day 14, IGFBP2 was downregulated by 60%. The CCL2 gene, otherwise known as MCP1, showed a 5.5-fold upregulation at Day 3 and a 4.3-fold upregulation at Day 14. Finally, the two most highly expressed genes, by far, were SPP1, also known as the osteopontin gene, and CXCL14, a chemokine. We found a steady increase in SPP1 from 30-fold upregulation (compared to the time zero aneurysm) to 45-fold upregulation at Day 14, and CXCL14 was upregulated approximately 30-fold throughout the time course.
The results of the evaluation of ECM-related genes were also subdivided by expression over time, upregulation, and downregulation (Table 6 ). Again, SPP1 was present, as might be expected, given that it was originally discovered in relation to bone formation. In the earlier phases of healing, TGFBI was upregulated, 2.4-fold at Day 3 and 3.3-fold at Day 7. The genes for several types of collagen were notably active: COL7A1 and COL16A1 were upregulated at Day 7, COL1A1 was upregulated at Days 7 and 14, and COL6A3 was upregulated at Day 14. Interestingly, fibronectin (FN1) was slightly upregulated by approximately twofold throughout the time course.
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Thrombosis and healing in the swine aneurysm model Quantitative real-time PCR was also performed on several genes for further evaluation (Table 7 and Fig. 10 ). Each aneurysm specimen was assayed individually, with no pooling. We found significant change in expression of IGF1 at Day 7 (2.7-fold) and Day 14 (3.4-fold). At Day 14, IGFBP5 showed an 80% upregulation, whereas CCL2 showed only a 40% upregulation, which was not statistically significant. The most striking results were for CXCL14, which showed increases in expression ranging from 183-fold to 330-fold. In light of the overwhelming increase in SPP1 expression demonstrated by microarray assay (up to 45-fold) and because there was only a limited amount of RNA available for analysis, we did not perform real-time PCR studies to evaluate SSP1 expression.
Discussion
In this model, our detailed, time course design demonstrated a three-stage healing process. Stage 1, the organization stage, consists of leukocyte and macrophage replacement of the acute thrombus. This stage generally peaks at 3 to 7 days after thrombus formation, with subsequent decline. Stage 2, the proliferative stage, consists of myofibroblast and fibroblast proliferation and infiltration, which is maximal at Day 14, with subsequent decline. Collagen and other ECM deposition begins at this time. Stage 3, the contraction stage, consists of continued progressive collagen deposition with aneurysm contraction. The observation that collagen deposition continues long after myofibroblast decline is consistent with the generally accepted idea that myofibroblasts are temporarily activated before collagenproducing fibroblasts. 11, 12, 16 The healing in our aneurysm model, however, demonstrated some unique features. First, aneurysm organization and healing occurred in a centripetal fashion. Macrophage and myofibroblast infiltration were both noted to proceed from the periphery to the center. This observation stands in contrast to the classical description of wound healing, in which the sources of cellular infiltration are the apposed edges of the disrupted surface. We did not observe disruption of the endothelial surface of the aneurysm wall or transmigration of cells from the connective tissue of the operative bed. In fact, this centripetal process of intraaneurysmal organization has also been noted in histological studies of human aneurysms treated with coil embolization. 2, 35 Additionally, TGF-␤2 and VEGF, two cytokines previously linked to traditional wound healing, 32 were not found to be significantly active in either immunohistochemical analysis or RNA studies. These findings strongly suggest that the organization process of the aneurysm model is not simply that of wound healing, but also incorporates other processes, such as thrombus organization. Our results also confirm that histological and molecular findings within the surgical model are, to some degree, worthy of extrapolation to human aneurysms in vivo.
Second, and more interestingly, we observed a fine reticular network of connective tissue extending form the periphery of the aneurysm, growing centripetally, with digitations toward the center of the thrombus. The results of staining this reticular network with Masson trichrome and Sirius red, as well as staining for collagen type I, were negative. The reticular network was observed to involve the entire aneurysm circumference and was not specific to the aneurysm dome or the suture interface. Centripetally mi- grating macrophages were also noted within this tissue. The distinctive time course of macrophage migration into the thrombus and the subsequent disappearance of the macrophages strongly suggest the possibility that macrophages play a key role in aneurysmal thrombus organization and may be linked to the genesis of the reticular tissue that we observed. To our knowledge, this reticular tissue is a novel finding and could represent a process that distinguishes wound healing from thrombus organization.
Our RNA profiling of the natural history of aneurysm healing/thrombosis also yielded interesting findings. It was notable that, within the group of significantly changed genes, there were, overall, more downregulated genes, relative to time zero reference, than upregulated genes. There are two likely contributing explanations for this: 1) Our control specimen consisted of a freshly created and thrombosed surgical aneurysm, hardly a quiescent state. Therefore, subsequent downregulation of a given gene could actually represent a return to a baseline level of expression after a very early activation response. Our choice of control specimens was dictated primarily by the hope of capturing a time zero state of the intraluminal thrombus. 2) It is extremely likely that pathological changes at the molecular level involve a spectrum of both activation and inhibitory pathways. Genes encoding tumor suppressors or transcription/translation inhibitors could easily be downregulated in the process of activating prothrombotic or proinflammatory processes. The results of other microarray gene-profiling studies involving other diseases in other organ systems have shown similar patterns of widespread gene downregulation. 5, 19, 44, 53 Our EASE analysis confirms the ability of annotation- which would be reflected in a large initial flux in the transcription of genes related to energy metabolism. This initial spike, which was evidenced in our study by the finding that genes representing 17 ontological terms were significantly active at Day 3, followed by relative inactivity, probably reflects the initial surgical nature of the aneurysm model and provides some reassurance that a confounding milieu of chronic inflammation is not present. Based on the analysis of histological and microarray data, we identified four gene products of particular interest: CXCL14, SPP1, IGF1, and IGFBP5. These gene products represent two distinct molecular strategies aimed at the acceleration of aneurysm occlusion, enhanced monocyte recruitment, and growth factor supplementation.
As described above, the results of our histological analysis strongly suggest that monocytes/macrophages play a central role in the thrombus organization process in our aneurysm model. Monocytes/macrophages have been described by other researchers as playing a central role in both thrombus organization 23 and wound healing 14,45,46 by producing a variety of cytokines and/or growth factors. The results of our microarray studies showed that the gene for CXCL14, a chemokine linked to macrophage activation, was upregulated by 30-fold, and the results of our PCR studies showed it to be upregulated by as much as 300-fold.
Breast-and kidney-expressed chemokine (BRAK or CXCL14) is a recently described CXC chemokine that was first isolated in breast and kidney tissues, 22 but was later found to be constitutively expressed in some normal tissues. Chemokines, or chemotactic cytokines, have been implicated in a wide variety of related functions, including leukocyte degranulation, apoptosis, atherogenesis, and neoplastic progression. 1, 49 Interestingly, CXCL14 has also been identified as a key monocyte-selective chemokine. Utilizing a cellular migration assay, Kurth et al. 28 have demonstrated chemotactic specificity of CXCL14 for circulating and prostaglandin E 2 -treated monocytes. This chemokine is therefore theorized to play a role in circulating monocyte migration into tissue in both physiological homeostasis and in the setting of inflammation. 37 Additionally, the results of more recent studies have highlighted the importance of CXCL14 for the chemotaxis and proliferation of dendritic cells, a macrophage subtype also critical for antigen presentation. 48, 50, 51 After the early stage infiltration of inflammatory cells, myofibroblast and fibrocellular infiltration was noted at Days 7 and 14. Interestingly, the results of our microarray study also showed that members of the IGF axis were transcriptionally active at this time. At Day 7, IGF1 was upregulated 4-fold, while IGF2 and IGFBP2 were downregulated by 50%. At Day 14, IGFBP2 was downregulated by 60%. Insulin-like growth factor-1 and IGF-2 3,10 are single-chain polypeptides that are produced at physiological levels primarily by the liver under the influence of growth hormone. Insulin-like growth factor-1 is also produced in smaller, cytokine-level amounts by other cell types, primarily vascular smooth muscle and endothelial cells. The actions of IGF-1 and IGF-2 are mediated by a spectrum of specific membrane receptors and binding proteins. In humans, the IGFBP family has at least six members, which serve as carrier proteins in the circulation as well as storage pools for IGF-1. Most studies of IGF-1 and IGFBPs have focused on their effect on and expression by vascular smooth muscle cells. The IGF axis has been frequently linked to atherosclerosis, abdominal aneurysm formation, and postinjury restenosis. Grant et al. 18 demonstrated that IGF-1, IGF-1R, and IGFBP1-5 were not detected in the smooth muscle cells of normal coronary arteries, but were elevated in atherosclerotic specimens. Nichols et al. 41 showed a 50% decrease in atherosclerotic lesion size in swine using anti-IGF-1 antibodies. The IGF-1 inhibitors angiopeptin and octreotide have been shown to prevent vascular smooth muscle cell proliferation and neointimal formation in rats after ballooninduced arterial injury. 57 Panek et al. 43 showed that IGF-1 levels were decreased by 50% in human aortic aneurysms, accompanied by tripling of the IGFBP1 and IGFBP3 levels and an increase in collagen degradation products. Given its well-documented ability to induce smooth muscle cell chemotaxis and proliferation, as well as to increase deposition of collagen and elastin, the IGF axis may prove useful in optimizing intracranial aneurysm thrombosis and healing.
Finally, microarray analysis also identified osteopontin (SPP1) as another molecular factor of interest, one with both chemokine and growth factor types of effects. In our study, SPP1 was upregulated by 30-fold at postthrombosis Day 3 and 45-fold at Day 14. The name of this phosphoprotein refers to its key function as a factor in bone matrix, where it mediates adhesion of osteoclasts to resorbing bone. However, SPP1 is expressed in a variety of cell types, most notably vascular smooth muscle cells and macrophages after vascular injury. It has been associated with vascular remodeling, atherosclerosis, stroke, and pulmonary hypertension. For example, SPP1 has been well-documented to activate adhesion and migration of smooth muscle cells and macrophages. 30, 52 Liaw et al. 31 demonstrated that incisional wounds in SPP1-deficient mice had abnormal matrix organization and deficient collagen fibrillogenesis; SPP1 has also been associated with the regulation of fibrosis following inflammation.
42 Isoda et al. 24 showed that transgenic mice with more than threefold global overexpression of SPP1 had a 73% increase in medial thickness of the aorta compared with controls and a threefold increase in medial thickening in response to angioplasty injury. This was accompanied by a 16-to 27-fold increase in relative smooth muscle cell migration. Myers and associates 40 showed that the vessels of SPP1-null mice had loosely organized collagen networks and that vascular remodeling in response to ligation injury was delayed in these animals.
Our histological and molecular analysis represents one of the most in-depth descriptions of a surgical aneurysm model yet. Before extrapolating our findings into the biological characteristics of aneurysms in humans, however, it is important to remember that our model is a surgical model. The process of thrombus organization that we observe in this model will be complicated to some degree by the superimposed inflammation and tissue granulation seen in any healing wound. This fact will definitely color any future applications of knowledge gained. This potential bias influenced our choice to use dual-channel microarrays. By directly cohybridizing time-zero reference RNA and RNA from later time points, we hoped to subtract the effect of the surgery and highlight only those genes that are up-or downregulated from the initial state of the tissue. Another notable caveat is that the surgical aneurysm dome is constructed of venous tissue. Histological examination of the typical berry aneurysms seen clinically reveal the absence of a true intima media, as well as a significantly attenuated intima/elastica. In comparison, our aneurysm dome contains all three classical histological levels (intima, media, and adventitia) in their normal venous proportions. The possible effects of these differences on intraluminal events are unknown. For example, one may theorize that the venous wall could act as a greater source of cells than would be seen in a typical berry aneurysm.
Despite these differences, this model is appropriate for our experimental question. Our scientific and clinical goal is to better understand, and hopefully accelerate, intraaneurysmal thrombus organization via endovascular coils or otherwise. Unfortunately, the tendency of in vivo aneurysms is to remain patent. The phenomenon of spontaneous aneurysm thrombosis has proven too sporadic to capture and study in detail. In contrast, in the surgical aneurysm model, intraluminal thrombosis can be induced. Black and German 4,17 demonstrated in experimental vein pouch aneurysms that the critical ratio of dome volume to ostial area was 25:1. At ratios below this value, aneurysms remained patent; above this value, they thrombosed. By creating aneurysms with a very small neck of 2 to 3 mm, we were able to reliably and predictably induce a homogeneous intraluminal thrombosis. Only with this degree of precision can we accurately track the process of thrombus organization over time. Thrombosis in a wide-necked aneurysm would be disturbed by excessive flow dynamics that would confound and shift the equilibrium of thrombosis towards recanalization.
This aneurysm model is not being used solely to understand what happens in vivo. We also want to emphasize that this is not a model that describes the natural history of berry aneurysms in humans, or how and why they recanalize. Rather, we have established this experimental model as the a priori ideal scenario-a morphologically similar aneurysm within which we can recreate spontaneous thrombosis and fibrosis. By studying and dissecting the surgical model, we hope to eventually gain the ability to manipulate the clinical aneurysm, either with modified coils or some other modality, to heal like the surgical model.
Conclusions
Our experimental and clinical goal is to understand and accelerate aneurysm thrombosis, thrombus organization, and healing. This investigation describes, in histological and molecular detail, a unique process of aneurysm healing characterized by a distinctive centripetal pattern of fibrocellular infiltration, macrophage migration, and a reticular network of connective tissue. In Part II of this report, 56 we describe the effect of several bioabsorbable polymers on this process. These polymers show considerable promise for the next-generation endovascular coil, one that would rapidly elicit a more complete and more stable intraaneurysmal barrier. 
